News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its "Large Cap Strategy". A copy of the letter is available to download here. The Strategy returned 3.42% net of fees, trailing the Russell 1000 Value Index's 13.87% …
Sharemaestro market context Price below Trend Line 52 weeks -52.3%This article provides a revenue breakdown for Zoetis, Inc. Class A (MUN:ZOE), highlighting its top-performing segment and geographical contributions. In the last fiscal year, the company generated €8.06 billion in revenue, with the Parasiticides segment contributing €1.99 billion and the United States accounting for …
Sharemaestro market context Price below Trend Line 52 weeks -52.3%Platinum Asset Management, an investment management company, released its Q2 2026 investor letter for "Platinum International Brands Fund". A copy of the letter can be downloaded here. The fund returned over 4% in the quarter but lost 14% over the past year, primarily due …
Sharemaestro market context Price below Trend Line 52 weeks -52.3%This article details the shareholder structure of Zoetis Inc (ZTS), outlining its major shareholders and institutional holdings. It provides a breakdown of individual shareholders and their proportions, categorizes shareholders by type, and presents institutional shareholding trends over several quarters. The report also lists recent …
Bronstein, Gewirtz & Grossman LLC has announced that a class action lawsuit has been filed against Zoetis Inc. (NYSE: ZTS) on behalf of investors who purchased securities between January 14, 2025, and May 6, 2026. The lawsuit alleges that Zoetis Inc. made false and …
Zoetis (ZTS) closed at $76.92 in the latest trading session, marking a +2.08% move from the prior day. This move outpaced the S&P 500's daily gain of 0.02%. On the other hand, the Dow registered a gain of 0.51%, and the technology-centric Nasdaq decreased …
Sharemaestro market context Price below Trend Line 52 weeks -56.8%Bank of Nova Scotia significantly reduced its stake in Zoetis Inc. (NYSE:ZTS) by 19% in the first quarter, selling over 21,000 shares but retaining a holding valued at approximately $11 million. The company's stock has faced downward pressure, trading near its 52-week low after …
Sharemaestro market context Price below Trend Line 52 weeks -52.3%This article provides a revenue breakdown for Zoetis, Inc. Class A (LSX:A1KBYX), detailing its top-performing segment and geographical contributions. In the last year, the company generated €8.06 billion in revenue, with Parasiticides being the leading segment and the United States accounting for the largest …
Glancy Prongay Wolke & Rotter LLP has announced a securities fraud class action lawsuit against Zoetis Inc. (NYSE: ZTS), inviting shareholders who suffered losses to participate. The lawsuit alleges that Zoetis made materially misleading statements between January 2025 and May 2026 by failing to …
Sharemaestro market context Price below Trend Line 52 weeks -56.8%Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Zoetis (ZTS) To Contact Them Directly To Discuss Their Options If you purchased or acquired Zoetis securities between January 14, 2025 and May 6, 2026 and …
Levi & Korsinsky, LLP has filed a securities class action lawsuit against Zoetis Inc. (NYSE:ZTS) on behalf of investors who suffered losses due to alleged securities fraud between January 14, 2025, and May 6, 2026. The lawsuit claims Zoetis made false statements and concealed …
Pomerantz LLP has filed a class action lawsuit against Zoetis Inc. (NYSE: ZTS) on behalf of investors who suffered losses. The lawsuit alleges securities fraud or unlawful business practices, following a significant drop in Zoetis's stock price after the company reported flat net income …
Moon Capital Management, LLC, an investment management company, released its second quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 index rebounded in the second quarter, achieving a 9.6% return for the first half of the year, …
Sharemaestro market context Price below Trend Line 52 weeks -52.3%Bernstein Liebhard LLP has announced a securities fraud class action lawsuit against Zoetis Inc. (NYSE: ZTS) on behalf of investors who purchased shares between January 14, 2025, and May 6, 2026. The lawsuit alleges that Zoetis made false and misleading statements, leading to artificially …
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the “Class Period”), of the important July 27, …
Sharemaestro market context Price below Trend Line 52 weeks -52.3%Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Zoetis (NYSE:ZTS) has launched Portela, a long acting monoclonal antibody therapy for osteoarthritis pain …
Sharemaestro market context Price below Trend Line 52 weeks -52.3%Bernstein Liebhard LLP reminds investors of Zoetis Inc. (NYSE: ZTS) that they have until July 27, 2026, to join a securities fraud class action lawsuit. The lawsuit alleges that Zoetis made false and misleading statements between January 14, 2025, and May 6, 2026, causing …
Zoetis Inc. is facing multiple class action lawsuits from shareholders who purchased securities between January 14, 2025, and May 6, 2026. The lawsuits allege that Zoetis made materially false and misleading statements that inflated stock prices, leading to significant investor losses. These claims stem …
First long-acting anti-NGF monoclonal antibody therapy for cats offers three months of osteoarthritis pain relief with a single injection PARSIPPANY, N.J., July 22, 2026--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today announced the commercial launch of Portela® (relfovetmab) in Canada and the European Union (EU) member …
Sharemaestro market context Price below Trend Line 52 weeks -52.3%In the latest close session, Zoetis (ZTS) was down 1.12% at $75.35. The stock's change was less than the S&P 500's daily gain of 0.89%. Elsewhere, the Dow gained 0.74%, while the tech-heavy Nasdaq added 1.29%. Shares of the animal health company witnessed a …
Sharemaestro market context Price below Trend Line 52 weeks -56.8%The Gross Law Firm has issued a shareholder alert for Zoetis Inc. (NYSE: ZTS), announcing a securities class action lawsuit. Investors who purchased ZTS shares between January 14, 2025, and May 6, 2026, are encouraged to contact the firm, possibly for lead plaintiff appointment. …
Sharemaestro market context Price below Trend Line 52 weeks -54.2%The Rosen Law Firm reminds investors who purchased Zoetis Inc. (NYSE: ZTS) securities between January 14, 2025, and May 6, 2026, of the July 27, 2026 lead plaintiff deadline in a securities fraud lawsuit. The lawsuit alleges that Zoetis made false and misleading statements …
Bragar Eagel & Squire, P.C. has announced a class action lawsuit against Zoetis, Inc. (NYSE:ZTS) for investors who purchased securities between January 14, 2025, and May 6, 2026. The lawsuit alleges that Zoetis made misleading statements and failed to disclose issues regarding its veterinary …
Glancy Prongay Wolke & Rotter LLP is urging Zoetis Inc. (ZTS) shareholders who suffered losses between January 14, 2025, and May 6, 2026, to contact them regarding a securities fraud lawsuit. The lawsuit alleges that Zoetis made misleading statements and failed to disclose issues …
LOS ANGELES, July 20, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming July 27, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Zoetis …
Sharemaestro market context Price below Trend Line 52 weeks -52.3%The Rosen Law Firm is urging Zoetis Inc. (NYSE: ZTS) stockholders who incurred losses exceeding $100,000 to contact them regarding a class action lawsuit. The lawsuit alleges that Zoetis made misleading statements about the performance of its animal health products, including Librela, Simparica Trio, …
LOS ANGELES, July 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Zoetis Inc. (“Zoetis” or “the Company”) (NYSE: ZTS) for violations of §§10(b) and 20(a) of the Securities Exchange …
Sharemaestro market context Price below Trend Line 52 weeks -54.2%This article provides the "Price to book forward" for Zoetis, Inc. Class A (MIL:1ZTS), listed on Euronext Milan. The financial data is noted as being made by humans and supported by select market data from ICE Data Services and reference data from FactSet. The …
Bronstein, Gewirtz & Grossman, LLC announced that a class action lawsuit has been filed against Zoetis Inc. (NYSE:ZTS) on behalf of investors who purchased securities between January 14, 2025, and May 6, 2026. The lawsuit alleges that Zoetis made false and misleading statements regarding …
Zoetis recently launched Lenivia for canine osteoarthritis pain and secured European approval for its Poulvac Procerta HVT-ND poultry vaccine, while simultaneously facing new securities class action lawsuits regarding alleged disclosure issues in its Companion Animal segment. This convergence of new product approvals and increased …
Affected ZTS Investor Summary Who: Zoetis Inc. (NYSE: ZTS)What: Securities fraud class action lawsuit filedClass Period: January 14, 2025 through May 6, 2026Deadline to Seek Lead Plaintiff Status: July 27, 2026Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company’s product adoption.Investor Action: Contact …
Sharemaestro market context Price below Trend Line 52 weeks -52.3%Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against Zoetis Inc. (ZTS) on behalf of investors who purchased securities between January 14, 2025, and May 6, 2026. The lawsuit alleges that Zoetis made false or misleading statements regarding …
SueWallSt is reminding investors that the lead plaintiff deadline for the securities class action lawsuit against Zoetis Inc. (ZTS) is July 27, 2026. The lawsuit alleges that Zoetis misled investors between January 14, 2025, and May 6, 2026, by concealing competitive erosion and safety-driven …
The Australian regulatory body, ACCC, is scrutinizing Zoetis' proposed $160 million acquisition of Neogen Genomics business due to significant competition concerns. Both companies are major genomic testing providers for livestock, and the ACCC worries about consolidation and the acquiring firm gaining exclusive access to …
Search by ticker symbol or company name and select a result to open its chart.